TCIM
MDT icon

TIAA CREF Investment Management’s Medtronic MDT Stock Holding History

TIAA CREF Investment Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$351M Sell
3,856,392
-828,528
-18% -$74.2M 0.25% 79
2018
Q4 		$426M Buy
4,684,920
+541,401
+13% +$50.6M 0.34% 59
2018
Q3 		$408M Buy
4,143,519
+110,169
+3% +$10.2M 0.27% 78
2018
Q2 		$345M Sell
4,033,350
-339,439
-8% -$28.4M 0.23% 94
2018
Q1 		$351M Buy
4,372,789
+114,701
+3% +$9.46M 0.24% 95
2017
Q4 		$344M Sell
4,258,088
-182,911
-4% -$14.6M 0.23% 96
2017
Q3 		$345M Sell
4,440,999
-596,639
-12% -$49.5M 0.24% 92
2017
Q2 		$447M Buy
5,037,638
+418,230
+9% +$35.3M 0.31% 69
2017
Q1 		$372M Sell
4,619,408
-793,068
-15% -$61.9M 0.27% 80
2016
Q4 		$386M Sell
5,412,476
-684,283
-11% -$53.8M 0.29% 77
2016
Q3 		$527K Sell
6,096,759
-75,578
-1% -$6.59M 0.33% 66
2016
Q2 		$536M Buy
6,172,337
+34,545
+0.6% +$2.79M 0.41% 53
2016
Q1 		$460M Sell
6,137,792
-780,463
-11% -$58.8M 0.35% 58
2015
Q4 		$532M Buy
6,918,255
+276,826
+4% +$20.8M 0.4% 54
2015
Q3 		$445M Buy
6,641,429
+333,694
+5% +$24.6M 0.35% 58
2015
Q2 		$467M Sell
6,307,735
-806,819
-11% -$61.6M 0.33% 59
2015
Q1 		$555M Buy
7,114,554
+2,039,816
+40% +$155M 0.39% 48
2014
Q4 		$366M Sell
5,074,738
-593,223
-10% -$41.2M 0.26% 84
2014
Q3 		$351M Buy
5,667,961
+163,879
+3% +$10.4M 0.25% 78
2014
Q2 		$351M Buy
5,504,082
+9,950
+0.2% +$604K 0.24% 85
2014
Q1 		$338M Sell
5,494,132
-74,619
-1% -$4.35M 0.24% 87
2013
Q4 		$320M Buy
5,568,751
+102,319
+2% +$5.8M 0.23% 93
2013
Q3 		$291M Sell
5,466,432
-1,417,908
-21% -$76.3M 0.23% 90
2013
Q2 		$354M Buy
+6,884,340
New +$340M 0.29% 70

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TIAA CREF Investment Management's MDT Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Medtronic (MDT) stake by 18% in Q1 2019, selling an estimated $74.2M and leaving 3,856,392 shares worth $351M. The position accounts for 0.25% of the portfolio, ranked #79.

TIAA CREF Investment Management first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $555M in Q1 2015. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • TIAA CREF Investment Management held 3,856,392 shares of Medtronic worth $351M as of Q1 2019.
  • TIAA CREF Investment Management sold 828,528 Medtronic shares in Q1 2019, an estimated $74.2M.
  • Medtronic made up 0.25% of TIAA CREF Investment Management's portfolio in Q1 2019, its #79 holding.
  • TIAA CREF Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Medtronic position peaked at $555M in Q1 2015.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.